These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21357822)

  • 41. DDiT4L promotes autophagy and inhibits pathological cardiac hypertrophy in response to stress.
    Simonson B; Subramanya V; Chan MC; Zhang A; Franchino H; Ottaviano F; Mishra MK; Knight AC; Hunt D; Ghiran I; Khurana TS; Kontaridis MI; Rosenzweig A; Das S
    Sci Signal; 2017 Feb; 10(468):. PubMed ID: 28246202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new model of congestive heart failure in the mouse due to chronic volume overload.
    Scheuermann-Freestone M; Freestone NS; Langenickel T; Höhnel K; Dietz R; Willenbrock R
    Eur J Heart Fail; 2001 Oct; 3(5):535-43. PubMed ID: 11595601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thioredoxin-2 inhibits mitochondrial reactive oxygen species generation and apoptosis stress kinase-1 activity to maintain cardiac function.
    Huang Q; Zhou HJ; Zhang H; Huang Y; Hinojosa-Kirschenbaum F; Fan P; Yao L; Belardinelli L; Tellides G; Giordano FJ; Budas GR; Min W
    Circulation; 2015 Mar; 131(12):1082-97. PubMed ID: 25628390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effects of various genetic mouse models of the mechanistic target of rapamycin complex I inhibition on heart failure.
    Dai DF; Liu Y; Basisty N; Karunadharma P; Dastidar SG; Chiao YA; Chen T; Beyer RP; Chin MT; Maccoss M; La Spada AR; Rabinovitch PS
    Geroscience; 2019 Dec; 41(6):847-860. PubMed ID: 31650481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comprehensive plasma and tissue profiling reveals systemic metabolic alterations in cardiac hypertrophy and failure.
    Müller OJ; Heckmann MB; Ding L; Rapti K; Rangrez AY; Gerken T; Christiansen N; Rennefahrt UEE; Witt H; González Maldonado S; Ternes P; Schwab DM; Ruf T; Hille S; Remes A; Jungmann A; Weis TM; Kreußer JS; Gröne HJ; Backs J; Schatz P; Katus HA; Frey N
    Cardiovasc Res; 2019 Jul; 115(8):1296-1305. PubMed ID: 30418544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thioredoxin-1 maintains mitochondrial function via mechanistic target of rapamycin signalling in the heart.
    Oka SI; Chin A; Park JY; Ikeda S; Mizushima W; Ralda G; Zhai P; Tong M; Byun J; Tang F; Einaga Y; Huang CY; Kashihara T; Zhao M; Nah J; Tian B; Hirabayashi Y; Yodoi J; Sadoshima J
    Cardiovasc Res; 2020 Aug; 116(10):1742-1755. PubMed ID: 31584633
    [TBL] [Abstract][Full Text] [Related]  

  • 47. mTOR, cardiomyocytes and inflammation in cardiac hypertrophy.
    Xu L; Brink M
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1894-903. PubMed ID: 26775585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heart-specific activation of LTK results in cardiac hypertrophy, cardiomyocyte degeneration and gene reprogramming in transgenic mice.
    Honda H; Harada K; Komuro I; Terasaki F; Ueno H; Tanaka Y; Kawamura K; Yazaki Y; Hirai H
    Oncogene; 1999 Jul; 18(26):3821-30. PubMed ID: 10445845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolically-modulated growth and phenotype of the rat heart.
    Rupp H; Jacob R
    Eur Heart J; 1992 Sep; 13 Suppl D():56-61. PubMed ID: 1396861
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Akt1 is required for physiological cardiac growth.
    DeBosch B; Treskov I; Lupu TS; Weinheimer C; Kovacs A; Courtois M; Muslin AJ
    Circulation; 2006 May; 113(17):2097-104. PubMed ID: 16636172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prdm16 Deficiency Leads to Age-Dependent Cardiac Hypertrophy, Adverse Remodeling, Mitochondrial Dysfunction, and Heart Failure.
    Cibi DM; Bi-Lin KW; Shekeran SG; Sandireddy R; Tee N; Singh A; Wu Y; Srinivasan DK; Kovalik JP; Ghosh S; Seale P; Singh MK
    Cell Rep; 2020 Oct; 33(3):108288. PubMed ID: 33086060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats.
    Kong SW; Bodyak N; Yue P; Liu Z; Brown J; Izumo S; Kang PM
    Physiol Genomics; 2005 Mar; 21(1):34-42. PubMed ID: 15623566
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy.
    McMullen JR; Shioi T; Zhang L; Tarnavski O; Sherwood MC; Dorfman AL; Longnus S; Pende M; Martin KA; Blenis J; Thomas G; Izumo S
    Mol Cell Biol; 2004 Jul; 24(14):6231-40. PubMed ID: 15226426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of autophagy in cardiac remodeling in transgenic mice with cardiac specific over-expression of human programmed cell death 5.
    An L; Zhao X; Wu J; Jia J; Zou Y; Guo X; He L; Zhu H
    PLoS One; 2012; 7(1):e30097. PubMed ID: 22253891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Knockout of the ATPase inhibitory factor 1 protects the heart from pressure overload-induced cardiac hypertrophy.
    Yang K; Long Q; Saja K; Huang F; Pogwizd SM; Zhou L; Yoshida M; Yang Q
    Sci Rep; 2017 Sep; 7(1):10501. PubMed ID: 28874825
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure.
    Thomas RL; Roberts DJ; Kubli DA; Lee Y; Quinsay MN; Owens JB; Fischer KM; Sussman MA; Miyamoto S; Gustafsson ÅB
    Genes Dev; 2013 Jun; 27(12):1365-77. PubMed ID: 23788623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin receptor substrate signaling suppresses neonatal autophagy in the heart.
    Riehle C; Wende AR; Sena S; Pires KM; Pereira RO; Zhu Y; Bugger H; Frank D; Bevins J; Chen D; Perry CN; Dong XC; Valdez S; Rech M; Sheng X; Weimer BC; Gottlieb RA; White MF; Abel ED
    J Clin Invest; 2013 Dec; 123(12):5319-33. PubMed ID: 24177427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physiological and pathological cardiac hypertrophy.
    Shimizu I; Minamino T
    J Mol Cell Cardiol; 2016 Aug; 97():245-62. PubMed ID: 27262674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mammalian target of rapamycin is essential for cardiomyocyte survival and heart development in mice.
    Zhang P; Shan T; Liang X; Deng C; Kuang S
    Biochem Biophys Res Commun; 2014 Sep; 452(1):53-9. PubMed ID: 25139234
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Successful TRPV1 antagonist treatment for cardiac hypertrophy and heart failure in mice.
    Horton JS; Buckley CL; Stokes AJ
    Channels (Austin); 2013 Jan; 7(1):17-22. PubMed ID: 23221478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.